{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:15:29Z","timestamp":1765728929191,"version":"3.38.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02111-w","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:56:36Z","timestamp":1741352196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unraveling a novel FBN1 variant in Marfan syndrome with dilated aortic root manifestation"],"prefix":"10.1186","volume":"18","author":[{"given":"Amirreza","family":"Sabahizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Askarinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saranaz Seyed","family":"AliAkbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdieh","family":"Soveizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golnaz","family":"Houshmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojjat","family":"Mortezaeian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Elahifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Kalayinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"2111_CR1","doi-asserted-by":"crossref","unstructured":"Von Kodolitsch Y, De Backer J, Sch\u00fcler H, Bannas P, Behzadi C, Bernhardt AM, Hillebrand M, Fuisting B, Sheikhzadeh S, Rybczynski M. Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome. Application Clin Genet 2015:137\u201355.","DOI":"10.2147\/TACG.S60472"},{"issue":"1","key":"2111_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cpcardiol.2007.10.001","volume":"33","author":"NM Ammash","year":"2008","unstructured":"Ammash NM, Sundt TM, Connolly HM. Marfan syndrome\u2014diagnosis and management. Curr Probl Cardiol. 2008;33(1):7\u201339.","journal-title":"Curr Probl Cardiol"},{"issue":"12","key":"2111_CR3","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/s41431-018-0164-9","volume":"26","author":"M Aubart","year":"2018","unstructured":"Aubart M, Gazal S, Arnaud P, Benarroch L, Gross M-S, Buratti J, Boland A, Meyer V, Zouali H, Hanna N. Association of modifiers and other genetic factors explain Marfan syndrome clinical variability. Eur J Hum Genet. 2018;26(12):1759\u201372.","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"2111_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/diagnostics10100751","volume":"10","author":"A Demolder","year":"2020","unstructured":"Demolder A, von Kodolitsch Y, Mui\u00f1o-Mosquera L, De Backer J. Myocardial function, heart failure and arrhythmia in Marfan syndrome: a systematic literature review. Diagnostics. 2020;10(10):751.","journal-title":"Diagnostics"},{"issue":"13","key":"2111_CR5","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.7150\/ijms.60685","volume":"18","author":"Q Du","year":"2021","unstructured":"Du Q, Zhang D, Zhuang Y, Xia Q, Wen T, Jia H. The molecular genetics of Marfan syndrome. Int J Med Sci. 2021;18(13):2752.","journal-title":"Int J Med Sci"},{"issue":"1","key":"2111_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/geno.1998.5697","volume":"56","author":"NJ Biery","year":"1999","unstructured":"Biery NJ, Eldadah ZA, Moore CS, Stetten G, Spencer F, Dietz HC. Revised genomic organization ofFBN1and significance for regulated gene expression. Genomics. 1999;56(1):70\u20137.","journal-title":"Genomics"},{"issue":"7","key":"2111_CR7","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/hmg\/2.7.961","volume":"2","author":"L Pereira","year":"1993","unstructured":"Pereira L, D\u2019Alessio M, Ramirez F, Lynch R, Sykes J, Pangilinan B, Bonadio T. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet. 1993;2(7):961\u20138.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2111_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1006\/geno.1993.1350","volume":"17","author":"GM Corson","year":"1993","unstructured":"Corson GM, Chalberg SC, Dietz HC, Charbonneau NL, Sakai LY. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5\u2032 end. Genomics. 1993;17(2):476\u201384.","journal-title":"Genomics"},{"key":"2111_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.matbio.2017.07.004","volume":"71","author":"F Ramirez","year":"2018","unstructured":"Ramirez F, Caescu C, Wondimu E, Galatioto J. Marfan syndrome; A connective tissue disease at the crossroads of mechanotransduction, TGF\u03b2 signaling and cell stemness. Matrix Biol. 2018;71:82\u20139.","journal-title":"Matrix Biol"},{"issue":"8","key":"2111_CR10","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/CIRCRESAHA.114.304936","volume":"116","author":"JD Humphrey","year":"2015","unstructured":"Humphrey JD, Schwartz MA, Tellides G, Milewicz DM. Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections. Circul Res. 2015;116(8):1448\u201361.","journal-title":"Circul Res"},{"issue":"3","key":"2111_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1083\/jcb.200608167","volume":"176","author":"SS Chaudhry","year":"2007","unstructured":"Chaudhry SS, Cain SA, Morgan A, Dallas SL, Shuttleworth CA, Kielty CM. Fibrillin-1 regulates the bioavailability of TGF\u03b21. J Cell Biol. 2007;176(3):355\u201367.","journal-title":"J Cell Biol"},{"issue":"5","key":"2111_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"7","key":"2111_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jmg.2009.072785","volume":"47","author":"BL Loeys","year":"2010","unstructured":"Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476\u201385.","journal-title":"J Med Genet"},{"issue":"6","key":"2111_CR14","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1083\/jcb.103.6.2499","volume":"103","author":"LY Sakai","year":"1986","unstructured":"Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol. 1986;103(6):2499\u2013509.","journal-title":"J Cell Biol"},{"issue":"12","key":"2111_CR15","doi-asserted-by":"publisher","first-page":"6751","DOI":"10.1074\/jbc.270.12.6751","volume":"270","author":"P Handford","year":"1995","unstructured":"Handford P, Downing AK, Rao Z, Hewett DR, Sykes BC, Kielty CM. The calcium binding properties and molecular organization of epidermal growth factor-like domains in human fibrillin-1. J Biol Chem. 1995;270(12):6751\u20136.","journal-title":"J Biol Chem"},{"issue":"7","key":"2111_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1042\/BJ20151108","volume":"473","author":"SA Jensen","year":"2016","unstructured":"Jensen SA, Handford PA. New insights into the structure, assembly and biological roles of 10\u201312 Nm connective tissue microfibrils from fibrillin-1 studies. Biochem J. 2016;473(7):827\u201338.","journal-title":"Biochem J"},{"issue":"2","key":"2111_CR17","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1074\/jbc.272.2.1231","volume":"272","author":"DP Reinhardt","year":"1997","unstructured":"Reinhardt DP, Ono RN, Sakai LY. Calcium stabilizes fibrillin-1 against proteolytic degradation. J Biol Chem. 1997;272(2):1231\u20136.","journal-title":"J Biol Chem"},{"key":"2111_CR18","doi-asserted-by":"crossref","unstructured":"Loeys 1 B, Delvaux LNI, De Bie S, De Paepe A. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome. Arch Intern Med 2001.","DOI":"10.1001\/archinte.161.20.2447"},{"issue":"9","key":"2111_CR19","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/humu.9505","volume":"28","author":"P Comeglio","year":"2007","unstructured":"Comeglio P, Johnson P, Arno G, Brice G, Evans A, Aragon-Martin J, da Silva FP, Kiotsekoglou A, Child A. The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193 FBN1 mutations. Hum Mutat. 2007;28(9):928.","journal-title":"Hum Mutat"},{"issue":"6","key":"2111_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s004390051150","volume":"105","author":"D Halliday","year":"1999","unstructured":"Halliday D, Hutchinson S, Kettle S, Firth H, Wordsworth P, Handford PA. Molecular analysis of eight mutations in FBN1. Hum Genet. 1999;105(6):587\u201397.","journal-title":"Hum Genet"},{"issue":"1","key":"2111_CR21","first-page":"877","volume":"18","author":"M Zhang","year":"2018","unstructured":"Zhang M, Zhou Y, Peng Y, Jin L. Two rare missense mutations in the fibrillin\u20131 gene associated with atypical cardiovascular manifestations in a Chinese patient affected by Marfan syndrome. Mol Med Rep. 2018;18(1):877\u201381.","journal-title":"Mol Med Rep"},{"issue":"7","key":"2111_CR22","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/ajmg.a.32918","volume":"149a","author":"BH Chung","year":"2009","unstructured":"Chung BH, Lam ST, Tong TM, Li SY, Lun KS, Chan DH, Fok SF, Or JS, Smith DK, Yang W, et al. Identification of novel FBN1 and TGFBR2 mutations in 65 probands with Marfan syndrome or Marfan-like phenotypes. Am J Med Genet A. 2009;149a(7):1452\u20139.","journal-title":"Am J Med Genet A"},{"issue":"41","key":"2111_CR23","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","volume":"35","author":"R Erbel","year":"2014","unstructured":"Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, et al. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European society of cardiology (ESC). Eur Heart J. 2014;35(41):2873\u2013926.","journal-title":"Eur Heart J"},{"key":"2111_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12265-011-9314-y","volume":"4","author":"DP Judge","year":"2011","unstructured":"Judge DP, Rouf R, Habashi J, Dietz HC. Mitral valve disease in Marfan syndrome and related disorders. J Cardiovasc Transl Res. 2011;4:741\u20137.","journal-title":"J Cardiovasc Transl Res"},{"issue":"3","key":"2111_CR25","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jtcvs.2014.06.046","volume":"148","author":"MR Helder","year":"2014","unstructured":"Helder MR, Schaff HV, Dearani JA, Li Z, Stulak JM, Suri RM, Connolly HM. Management of mitral regurgitation in Marfan syndrome: outcomes of valve repair versus replacement and comparison with myxomatous mitral valve disease. J Thorac Cardiovasc Surg. 2014;148(3):1020\u20134.","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02111-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02111-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02111-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:56:39Z","timestamp":1741352199000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-025-02111-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2111"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02111-w","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complies with the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committees of Rajaie Cardiovascular Institute, Tehran, Iran (IR.RHC.REC.1400.005). Informed consent to participate was obtained from all of the participants and the parents or legal guardians of participant under the age of 16 in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that all the participants and parents of the minor participant gave written informed consent for their personal or clinical details along with any identifying images to be published in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}